Works matching AU Tang, Qi-Zhu
Results: 79
Myricetin attenuated LPS induced cardiac injury in vivo and in vitro.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 7, p. 1, doi. 10.1038/s41419-021-03922-2
- By:
- Publication type:
- Article
TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 7, p. N.PAG, doi. 10.1038/s41419-019-1718-7
- By:
- Publication type:
- Article
Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1617-y
- By:
- Publication type:
- Article
Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-017-0123-3
- By:
- Publication type:
- Article
Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2017, p. 1, doi. 10.1155/2017/8370593
- By:
- Publication type:
- Article
Does propofol suppress nitrosative stress during aortic surgery in pigs?
- Published in:
- 2006
- By:
- Publication type:
- Letter
Salidroside ameliorates pathological cardiac hypertrophy via TLR4‐TAK1‐dependent signaling.
- Published in:
- Phytotherapy Research, 2023, v. 37, n. 5, p. 1839, doi. 10.1002/ptr.7701
- By:
- Publication type:
- Article
Therapeutic Potential of Polyphenols in Cardiac Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00122
- By:
- Publication type:
- Article
Cardiac tumour necrosis factor receptor-associated factor 7 mediates the ubiquitination of apoptosis signal-regulating kinase 1 and aggravates cardiac hypertrophy.
- Published in:
- Cardiovascular Research, 2024, v. 120, n. 16, p. 2031, doi. 10.1093/cvr/cvae217
- By:
- Publication type:
- Article
Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.
- Published in:
- Cardiovascular Research, 2024, v. 120, n. 9, p. 1051, doi. 10.1093/cvr/cvae077
- By:
- Publication type:
- Article
C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 6, p. 1067, doi. 10.1093/cvr/cvy279
- By:
- Publication type:
- Article
Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs.
- Published in:
- Mediators of Inflammation, 2019, p. 1, doi. 10.1155/2019/6168340
- By:
- Publication type:
- Article
Evodiamine attenuates TGF-β1-induced fibroblast activation and endothelial to mesenchymal transition.
- Published in:
- Molecular & Cellular Biochemistry, 2017, v. 430, n. 1/2, p. 81, doi. 10.1007/s11010-017-2956-6
- By:
- Publication type:
- Article
Apigenin alleviates STZ-induced diabetic cardiomyopathy.
- Published in:
- Molecular & Cellular Biochemistry, 2017, v. 428, n. 1/2, p. 9, doi. 10.1007/s11010-016-2913-9
- By:
- Publication type:
- Article
Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.
- Published in:
- Molecular & Cellular Biochemistry, 2016, v. 417, n. 1/2, p. 87, doi. 10.1007/s11010-016-2716-z
- By:
- Publication type:
- Article
Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
- Published in:
- Molecular & Cellular Biochemistry, 2015, v. 409, n. 1/2, p. 145, doi. 10.1007/s11010-015-2520-1
- By:
- Publication type:
- Article
Protective Effect of Propofol and Its Relation to Postoperation Recovery in Children Undergoing Cardiac Surgery with Cardiopulmonary Bypass.
- Published in:
- Pediatric Cardiology, 2011, v. 32, n. 7, p. 940, doi. 10.1007/s00246-011-0018-5
- By:
- Publication type:
- Article
HINT2 protects against pressure overload‐induced cardiac remodelling through mitochondrial pathways.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 8, p. 1, doi. 10.1111/jcmm.18276
- By:
- Publication type:
- Article
TLR9 deficiency alleviates doxorubicin‐induced cardiotoxicity via the regulation of autophagy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 18, p. 10913, doi. 10.1111/jcmm.15719
- By:
- Publication type:
- Article
Zingerone attenuates aortic banding‐induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 9, p. 6466, doi. 10.1111/jcmm.14540
- By:
- Publication type:
- Article
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 8, p. 5715, doi. 10.1111/jcmm.14485
- By:
- Publication type:
- Article
Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
- Published in:
- Basic Research in Cardiology, 2018, v. 113, n. 5, p. 1, doi. 10.1007/s00395-018-0698-6
- By:
- Publication type:
- Article
T-bet deficiency attenuates cardiac remodelling in rats.
- Published in:
- Basic Research in Cardiology, 2018, v. 113, n. 3, p. 1, doi. 10.1007/s00395-018-0678-x
- By:
- Publication type:
- Article
Quality of Life and Cost for Patients with Premature Ventricular Contractions by Radiofrequency Catheter Ablation.
- Published in:
- Pacing & Clinical Electrophysiology, 2006, v. 29, n. 4, p. 343, doi. 10.1111/j.1540-8159.2006.00351.x
- By:
- Publication type:
- Article
Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy.
- Published in:
- Journal of Cellular Biochemistry, 2017, v. 118, n. 11, p. 3899, doi. 10.1002/jcb.26041
- By:
- Publication type:
- Article
Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
- Published in:
- Journal of Cellular Biochemistry, 2013, v. 114, n. 5, p. 1058, doi. 10.1002/jcb.24445
- By:
- Publication type:
- Article
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 110, n. 5, p. 1111, doi. 10.1002/jcb.22623
- By:
- Publication type:
- Article
Breviscapine protects against cardiac hypertrophy through blocking PKC-α-dependent signaling.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 109, n. 6, p. 1158, doi. 10.1002/jcb.22495
- By:
- Publication type:
- Article
Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 4, p. 1313, doi. 10.1159/000478960
- By:
- Publication type:
- Article
Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 1, p. 26, doi. 10.1159/000486220
- By:
- Publication type:
- Article
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 6, p. 2212, doi. 10.1159/000486026
- By:
- Publication type:
- Article
Fibronectin type III domain‐containing 5 improves aging‐related cardiac dysfunction in mice.
- Published in:
- Aging Cell, 2022, v. 21, n. 3, p. 1, doi. 10.1111/acel.13556
- By:
- Publication type:
- Article
Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/8593617
- By:
- Publication type:
- Article
Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.587438
- By:
- Publication type:
- Article
IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40639-6
- By:
- Publication type:
- Article
Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39159-0
- By:
- Publication type:
- Article
Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2019, p. 1, doi. 10.1155/2019/7901735
- By:
- Publication type:
- Article
Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2018, p. 1, doi. 10.1155/2018/6053727
- By:
- Publication type:
- Article
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice.
- Published in:
- PPAR Research, 2019, p. 1, doi. 10.1155/2019/2601408
- By:
- Publication type:
- Article
Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.
- Published in:
- PPAR Research, 2017, p. 1, doi. 10.1155/2017/2647129
- By:
- Publication type:
- Article
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
- Published in:
- PPAR Research, 2017, p. 1, doi. 10.1155/2017/5789714
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis.
- Published in:
- PPAR Research, 2016, p. 1, doi. 10.1155/2016/2198645
- By:
- Publication type:
- Article
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.
- Published in:
- PPAR Research, 2016, p. 1, doi. 10.1155/2016/9174190
- By:
- Publication type:
- Article
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.870699
- By:
- Publication type:
- Article
Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48970-2
- By:
- Publication type:
- Article
Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2023, p. 1, doi. 10.1155/2023/4015199
- By:
- Publication type:
- Article